|
Swiss 3T3 Cells
|
D041701 |
[A cell line established in 1962 from disaggregated Swiss albino mouse embryos. This fibroblast cell line is extremely popular in research.
] |
|
Bacillus cereus
|
B03.510.100.100.218.252 |
|
|
Calcium-Binding Proteins
|
D002135 |
[Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS.
] |
|
Glucagon-Like Peptide Receptors
|
D12.776.543.750.695.021 |
|
|
Receptors, Kisspeptin-1
|
D12.776.543.750.695.022 |
|
|
Orexin Receptors
|
D12.776.543.750.695.023 |
|
|
Malaria, Cerebral
|
D016779 |
[A condition characterized by somnolence or coma in the presence of an acute infection with PLASMODIUM FALCIPARUM (and rarely other Plasmodium species). Initial clinical manifestations include HEADACHES; SEIZURES; and alterations of mentation followed by a rapid progression to COMA. Pathologic features include cerebral capillaries filled with parasitized erythrocytes and multiple small foci of cortical and subcortical necrosis. (From Adams et al., Principles of Neurology, 6th ed, p136)
] |
|
BALB 3T3 Cells
|
D041702 |
[Cell lines developed from disaggregated BALB/c mouse embryos. They are extremely sensitive to CONTACT INHIBITION, and highly susceptible to transformation by SV40 VIRUS and murine sarcoma virus (SARCOMA VIRUSES, MURINE).
] |
|
Receptor, Anaphylatoxin C5a
|
D12.776.543.750.695.024 |
|
|
California
|
D002140 |
[State bounded on the east by Nevada and Arizona, on the south by Mexico and the Pacific Ocean on the south and west, and on the north by Oregon.
] |
|
Okadaic Acid
|
D23.946.580.710 |
|
|
Leishmaniasis, Cutaneous
|
D016773 |
[An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
] |
|
Leishmaniasis, Diffuse Cutaneous
|
D016774 |
[A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement.
] |
|
Agent Orange
|
D02.309.500.450.500 |
|
|
Norepinephrine Plasma Membrane Transport Proteins
|
D12.776.157.530.562.374.500.750 |
|
|
Catecholamine Plasma Membrane Transport Proteins
|
D12.776.157.530.562.374.500 |
|
|
Acupressure
|
E02.190.599.750.500 |
|
|
Malaria, Falciparum
|
D016778 |
[Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.
] |
|
Blastocystis Infections
|
D016776 |
[Infections with organisms of the genus BLASTOCYSTIS. The species B. hominis is responsible for most infections. Parasitologic surveys have generally found small numbers of this species in human stools, but higher positivity rates and organism numbers in AIDS patients and other immunosuppressed patients (IMMUNOCOMPROMISED HOST). Symptoms include ABDOMINAL PAIN; DIARRHEA; CONSTIPATION; VOMITING; and FATIGUE.
] |
|
Luteinizing Hormone
|
D06.472.699.322.576.463 |
|
